RS2 invests in medical device components maker KMM Group

In conjunction with the investment, KMM has named J. Mark King as president and CEO.

27 July 2026•1 min read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.